Search research articles
Contact Us
Filters
Showing results (1-10 of 29) with videos related to
Page
of 3
Sort By:
Cancer Discovery
|
April 3, 2021
T Cells as the Future of Cancer Therapy
Antoni Ribas
Cancer Discovery
|
August 15, 2015
Adaptive Immune Resistance: How Cancer Protects from Immune Attack
Antoni Ribas
Cancer Discovery
|
May 3, 2020
Trying for a BRAF Slam Dunk
Antoni Ribas, Roger S Lo
Cancer Discovery
|
October 5, 2022
When Cancer Cells Become the Enablers of an Antitumor Immune Response
Antoni Ribas, W Nicholas Haining, Ton N M Schumacher
Cancer Discovery
|
April 13, 2021
Repurposing of Anticancer Drugs Expands Possibilities for Antiviral and Anti-Inflammatory Discovery in COVID-19
Mihaela Aldea, Jean-Marie Michot, Francois-Xavier Danlos, et al.
Cancer Discovery
|
July 22, 2021
Rethinking Cancer Clinical Trial Conduct Induced by COVID-19: An Academic Center, Industry, Government, and Regulatory Agency Perspective
Keith T Flaherty, James H Doroshow, Susan Galbraith, et al.
Cancer Discovery
|
July 24, 2020
Epigenetic Suppression of Transgenic T-cell Receptor Expression via Gamma-Retroviral Vector Methylation in Adoptive Cell Transfer Therapy
Theodore S Nowicki, Colin Farrell, Marco Morselli, et al.
Cancer Discovery
|
December 23, 2020
Priority COVID-19 Vaccination for Patients with Cancer while Vaccine Supply Is Limited
Antoni Ribas, Rajarshi Sengupta, Trevan Locke, et al.
Cancer Discovery
|
April 29, 2021
Reducing Skin Toxicities from EGFR Inhibitors with Topical BRAF Inhibitor Therapy
Mario E Lacouture, Zev A Wainberg, Anisha B Patel, et al.
Cancer Discovery
|
June 15, 2018
Immunotherapy Resistance by Inflammation-Induced Dedifferentiation
Arnav Mehta, Yeon Joo Kim, Lidia Robert, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 29) with videos related to
Sort By:
Page
of 3
Cancer Discovery
|
April 3, 2021
T Cells as the Future of Cancer Therapy
Antoni Ribas
Cancer Discovery
|
August 15, 2015
Adaptive Immune Resistance: How Cancer Protects from Immune Attack
Antoni Ribas
Cancer Discovery
|
May 3, 2020
Trying for a BRAF Slam Dunk
Antoni Ribas, Roger S Lo
Cancer Discovery
|
October 5, 2022
When Cancer Cells Become the Enablers of an Antitumor Immune Response
Antoni Ribas, W Nicholas Haining, Ton N M Schumacher
Cancer Discovery
|
April 13, 2021
Repurposing of Anticancer Drugs Expands Possibilities for Antiviral and Anti-Inflammatory Discovery in COVID-19
Mihaela Aldea, Jean-Marie Michot, Francois-Xavier Danlos, et al.
Cancer Discovery
|
July 22, 2021
Rethinking Cancer Clinical Trial Conduct Induced by COVID-19: An Academic Center, Industry, Government, and Regulatory Agency Perspective
Keith T Flaherty, James H Doroshow, Susan Galbraith, et al.
Cancer Discovery
|
July 24, 2020
Epigenetic Suppression of Transgenic T-cell Receptor Expression via Gamma-Retroviral Vector Methylation in Adoptive Cell Transfer Therapy
Theodore S Nowicki, Colin Farrell, Marco Morselli, et al.
Cancer Discovery
|
December 23, 2020
Priority COVID-19 Vaccination for Patients with Cancer while Vaccine Supply Is Limited
Antoni Ribas, Rajarshi Sengupta, Trevan Locke, et al.
Cancer Discovery
|
April 29, 2021
Reducing Skin Toxicities from EGFR Inhibitors with Topical BRAF Inhibitor Therapy
Mario E Lacouture, Zev A Wainberg, Anisha B Patel, et al.
Cancer Discovery
|
June 15, 2018
Immunotherapy Resistance by Inflammation-Induced Dedifferentiation
Arnav Mehta, Yeon Joo Kim, Lidia Robert, et al.
Page
of 3